[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100637876":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":35,"responsibleParty":48,"collaborators":20,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":52,"sex":58,"minAge":59,"maxAge":20,"enrollmentInfo":60,"targetDuration":20,"studyType":63,"phases":64,"briefSummary":66,"conditions":67,"keywords":69,"overallStatus":72,"whyStopped":20,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"SCF Pharma","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"MagOX topic treatment","EXPERIMENTAL","Subjects will receive the daily treatment with MagOX serum and cream",[13],"Other: Omega-3 monoglyceride based topical treatment",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"OTHER","Omega-3 monoglyceride based topical treatment","Successive daily application of omega-3 monoglyceride based serum and cream on skin with eczema.",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Samuel Fortin, PhD","PRINCIPAL_INVESTIGATOR",[26,31],{"name":27,"role":28,"phone":29,"phoneExt":20,"email":30},"Samuel Fortin, PhD, PhD","CONTACT","418-750-8590","sfortin@scfpharma.com",{"name":32,"role":28,"phone":33,"phoneExt":20,"email":34},"Anne-Julie Landry, M.Sc, M.Sc","418-360-7480","ajlandry@ircl.ca",[36],{"facility":5,"status":20,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":20},"Rimouski","Quebec","G0K 1P0","Canada","CA",{"type":43,"coordinates":44},"Point",[45,46],-68.52396,48.44879,{"lat":46,"lon":45},{"type":49,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100637876","impact-of-a-daily-application-of-an-omega-3-monoglycerides-based-serum-and-cream-on-the-skin-microbiota-100637876",false,"NCT07583121","Impact of a Daily Application of an Omega-3 Monoglycerides Based Serum and Cream on the Skin Microbiota","Impact of a Daily Application of an Omega-3 Monoglycerides Based Serum and Cream on the Ratio of 4 Bacteria of the Skin Microbiota (Staphylococcus Aureus, Staphylococcus Epidermis, Cutibacterium Acnes and Streptococcus Pyogenes). Exploratory Study (COS-PBP-03).","COS-PBP-03","Inclusion Criteria:\n\n1. Participant aged of at least 18 years old.\n2. Participant diagnosed with eczema who did not use corticosteroids in the 14 days prior to study day 1;\n3. Available for the entire duration of the study and willing to participate based on the information provided in the ICF duly read and signed by the latter.\n4. Participant without intellectual problems likely to limit the validity of consent to participate in the study and compliance with protocol requirements, having the ability to cooperate adequately, understand and observe the instructions of research staff\n\nExclusion Criteria:\n\n* None","ALL","18 Years",{"count":61,"type":62},10,"ESTIMATED","INTERVENTIONAL",[65],"NA","This exploratory study aims to investigate the prebiotic potential of daily application of an omega-3 serum and cream to skin affected by eczema. The study will also collect data on any potential adverse effects of the products. Ten subjects will be enrolled in the study and will receive the same treatment for fourteen days. Their baseline condition before treatment will serve as a control for the effects observed after treatment on the targeted eczema area. A second area of eczema treated with the patient's usual skincare routine will also serve as a control.",[68],"Eczema",[70,71],"Skin hydration","Skin inflammation","NOT_YET_RECRUITING","2026-05-06",{"date":75,"type":76},"2026-05-13","ACTUAL",{"date":78,"type":62},"2026-05-04",{"date":80,"type":62},"2026-12-18",{"name":5,"class":6},1]